Your browser doesn't support javascript.
loading
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic Activity.
Spencer, Helen L; Jover, Eva; Cathery, William; Avolio, Elisa; Rodriguez-Arabaolaza, Iker; Thomas, Anita C; Alvino, Valeria V; Sala-Newby, Graciela; Dang, Zexu; Fagnano, Marco; Reni, Carlotta; Rowlinson, Jonathan; Vono, Rosa; Spinetti, Gaia; Beltrami, Antonio P; Gargioli, Cesare; Caporali, Andrea; Angelini, Gianni; Madeddu, Paolo.
Afiliação
  • Spencer HL; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Jover E; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Cathery W; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Avolio E; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Rodriguez-Arabaolaza I; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Thomas AC; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Alvino VV; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Sala-Newby G; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Dang Z; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Fagnano M; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Reni C; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Rowlinson J; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Vono R; IRCCS Multimedica, Milan, Italy (R.V., G.S.).
  • Spinetti G; IRCCS Multimedica, Milan, Italy (R.V., G.S.).
  • Beltrami AP; Department of Medical and Biological Sciences, University of Udine, Italy (A.P.B.).
  • Gargioli C; Cell Biology and Neurobiology Institute, National Research Council of Italy (CNR), Rome, Italy (C.G.).
  • Caporali A; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom (A.C.).
  • Angelini G; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
  • Madeddu P; From the Bristol Heart Institute, Bristol Medical School, Translational Health Sciences, University of Bristol, United Kingdom (H.L.S., E.J., W.C., E.A., I.R.-A., A.C.T., V.V.A., G.S.-N., Z.D., M.F., C.R., J.R., G.A., P.M.).
Arterioscler Thromb Vasc Biol ; 39(6): 1113-1124, 2019 06.
Article em En | MEDLINE | ID: mdl-31018661
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Veia Safena / Glicoproteínas de Membrana / Movimento Celular / Músculo Esquelético / Neovascularização Fisiológica / Pericitos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Veia Safena / Glicoproteínas de Membrana / Movimento Celular / Músculo Esquelético / Neovascularização Fisiológica / Pericitos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos